The epidemiology of venous thromboembolism in the community.

By J. Heit. Arteriosclerosis, Thrombosis and Vascular Biology, 2008

696 citations recorded by the source corpus.

Subfields: Hematology, Internal Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/12b26409eb0d83ab25f8f8d838f726b6d6a364d7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. P. Pappas
2. L. Kabnick
3. G. Raskob
4. S. Konstantinides

In Internal Medicine

1. P. Pappas
2. L. Kabnick
3. Aaron M. Wendelboe
4. A. Gallus
5. G. Agnelli
6. G. Raskob
7. S. Konstantinides
8. H. Büller

In Surgery

1. P. Pappas
2. L. Kabnick
3. Aaron M. Wendelboe
4. G. Raskob

Citations in the corpus

• Selected Phlebology Abstracts (2011, positive): “The incidence of posthrombotic venous ulcers has not changed in the past 2 ecades for women, and it recently increased in men.(58) In he United States each year, at least 20,556 patients receive new diagnosis of venous ulcers.”
• [2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. (2014, positive): “It is the third most frequent cardiovascular disease with an overall annual incidence of 100–200 per 100 000 inhabitants.(1,2) VTE may be lethal in the acute phase or lead to chronic disease and disability,(3) –6 but it is also often preventable.”
• Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo (2012, neutral): “The incidence of VTE increases dramatically over 45 yr of age and ranges from 300,000 to more than two million per year in the United States with similar rates in Europe (Cohen et al., 2007; Heit, 2008; Moll and Mackman, 2008).”
• ESC Guidelines on the diagnosis and management of acute pulmonary embolism (2014, positive): “It is the third most frequent cardiovascular disease with an overall annual incidence of 100–200 per 100 000 inhabitants.(1,2) VTE may be lethal in the acute phase or lead to chronic disease and disability,(3) –6 but it is also often preventable.”
• Thrombosis: A major contributor to global disease burden (2014, positive): “Future efforts of the GBD study should include evaluation of VTE as a cause of death and the associated DALYs, both for hospital- associated events, which account for up to 60% of all VTE (78), and also for events that occur outside the hospital setting, such as unprovoked VTE Prevention is the key ”
• Thrombosis: A Major Contributor to Global Disease Burden (2014, positive): “A similar approach applied to the data from the United States suggested ≈300 000 deaths from VTE each year.(78,79) The”